Article Text

Download PDFPDF
Gynecologic Oncologist Perspective About ESMO-ESGO-ESTRO Consensus Conference on Endometrial Cancer
  1. Polat Dursun, MD and
  2. Ali Ayhan, MD
  1. Division of Gynecologic Oncology, Department of Obstetrics & Gynecology, Baskent University School of Medicine, Ankara, Turkey.
  1. Address correspondence and reprint requests to Polat Dursun, MD, Division of Gynecologic Oncology, Department of Obstetrics&Gynecology, Baskent University School of Medicine, Kubilay Sk No 36 Maltepe, Ankara, Turkey. E-mail: pdursun{at}yahoo.com.

Abstract

Abstract ESMO-ESGO-ESTRO Consensus Conference on Endometrial Cancer was simultaneously published in 3 prestigious journals and is sure to have a huge impact on the clinical practice of gynecologic oncology community and other gynecologic cancer care providers.

It is a tremendous report representative of great effort. Hovewer, as practicing gynecologic oncologists, endometrial carcinoma is the most common clinical entity encountered in our routine daily practice; as such, we find some of the report confusing and object to some of its findings, as detailed in this brief report.

We also attempted to summarize the differences between the well-known NCCN guidelines and the ESMO-ESGO-ESTRO Consensus Conference guidelines and try to give the point of view of gynecologic oncologic perspective. It is obvious that differences in the management of endometrial carcinomas will continue to be debated by the scientific community.

  • Endometrial cancer
  • ESMO-ESGO-ESTRO Consensus Conference on Endometrial Cancer

Statistics from Altmetric.com

Footnotes

  • The authors declare no conflicts of interest.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.